Product
Supplier
Encyclopedia
Inquiry
Peptides Powder High Quality Vesugen buy - large image1
Peptides Powder High Quality Vesugen buy - image1
Peptides Powder High Quality Vesugen buy - image2
Peptides Powder High Quality Vesugen buy - image3
Peptides Powder High Quality Vesugen buy - image4
Peptides Powder High Quality Vesugen buy - image5
Peptides Powder High Quality Vesugen buy - image6

Peptides Powder High Quality Vesugen

ISO COA 8 Inquiries

Unit Price: Get Latest Price
CAS No.:

204271-66-9

Grade:

Pharmaceutical Grade

Port:

BJ

Packaging:

Vial box

Price valid (until):

2026-03-06

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Weight Loss Peptide GLP-1 Retatrutide Mt2 Motsc Ghk Cu Epithalon 99% Purity Peptides

    Purity: >98%
    Storage: Dry, dark, and at 0 - 4 C for the short term (days to weeks) or -20 C for the long term (months to years).
    Solubility: Soluble in DMSO
    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Peptide : A New Hope for Obesity Treatment
    Obesity is a complex metabolic disorder that affects millions of people worldwide. It is associated with various health risks including cardiovascular diseases, diabetes, and some forms of cancer. Despite the development of several weight-loss strategies, the number of obese people continues to rise. This prompts the need for new and effective anti-obesity drugs. One such promising drug is peptide Trizepatide.
    Peptides are short chains of amino acids that have biological functions in the body. Trizepatide is a novel peptide that acts on three targets: the glucagon-like peptide-1 (GLP-1) receptor, the gastric inhibitory peptide (GIP) receptor, and the glucagon receptor. These receptors are involved in the regulation of glucose and energy metabolism in the body. By activating these receptors, Trizepatide can increase secretion,decrease appetite, and promote fat burning.

    Reta is the newest GLP-1R agonist and was approved by the FDA as a once-weekly injection for the treatment of T2DM in late 2017. The peptide is chemically similar to liraglutide, with the inclusion of two structural modifications (Lau, Bloch, et al., 2015). The first is the replacement of Gly with the non-proteinogenic amino acid 2-aminoisobutyric acid (Aib) at position 2. The second is the attachment of octadecanoic diacid to the side chain of Lys-26 through a short polyethylene glycol (PEG) spacer and a γ-glutamic acid linker. The amino acid substitution renders the peptide more resistant to DPP-4 compared to liraglutide, and the presence of the 18-carbon fatty acid moiety results in a high binding affinity for serum albumin, which translates to a half-life of approximately 7 days in humans.

    Shop Peptides Powder High Quality Vesugen-Detailed Image 1

    Q1: When will the product be shipped after payment?
      ---We are committed to the same day shipping.

    Q2. How does your factory control quality?
    All the raw material purchasing and production quality control are strictly following the ISO9001: 2008 management system. Besides, the full-featured detection equipment and GMP quality management system provided the strongest guarantee for a high-quality product.


    Q3: How long will it take to receive the parcel?
       --3 days for the US market; 4-6 days for the others.

    Q4: What can I do if I don't have the ability to clear the custom?
       --We got experience after doing export for many years, so don't worry we can handle that.

    Q5: Can I get some samples?
       ---Yes.

    Certificates

    Basic Info
    Product Name:

    L-Aspartic acid, L-lysyl-L-α-glutamyl-

    Other Name:

    L-Aspartic acid, L-lysyl-L-α-glutamyl-;Visugen

    CAS No.:

    204271-66-9

    Molecular Formula:

    C15H26N4O8

    InChIKeys:

    LLSUNJYOSCOOEB-GUBZILKMSA-N

    Molecular Weight:

    390.39

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.392±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

    Boiling Point:

    801.365±65.00 °C(Press: 760.00 Torr)(predicted)

    PKA:

    2.797±0.10(predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    8 Inquiries
    Country Product Purchase Quantity Date Posted
    Mexico

    Vesugen

    1 KG Jan 14, 2026
    United States

    Vesugen

    10 PCS Jun 7, 2026
    United States

    Vesugen

    1 G Mar 26, 2026
    United States

    vesugen

    10 PCS Jun 7, 2026
    Australia

    Vesugen

    10 MG May 28, 2026
    Netherlands

    Vesugen

    1 G Apr 27, 2026
    United States

    Vesugen

    200 MG Apr 9, 2026
    United States

    vesugen

    2 G Mar 10, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.